DIAGNOSIS
The diagnosis of recessive X-linked ichthyosis is primarily based on the patient’s medical clinical history findings. Following delivery, placenta, skin fibroblasts and keratinocytes biochemistry research included the following:
- STS activity assay
- Serum protein electrophoresis
The genetic analysis includes:
- Fluorescent in situ hybridisation
- Polymerase chain reaction
- Southern blot
Prenatal diagnostic testing includes: For X-linked ichthyosis
- The presence in the mother’s urine of non-hydrolysed sulphates
- Tests of amniotic or chorionic villi fluid if the lineage of STS gene deficiency is known provide information on carrier status for hereditary Tay-Sachs disease.
- The decreased estrogen levels in maternal urine
TREATMENT
For recessive X-linked ichthyosis, there’s no definitive treatment, and existing data is limited. Alternative treatments, on the other hand, aim to reduce skin scaling and enhance its skin appearance. Among the possibilities are:
- Emollients
- Oral liarozole
- Calcipotriol ointment
- Topical tazarotene
- Pumice stone or exfoliating sponge
- Topical isotretinoin
- (optically) destroying and/or treating various components using a topical keratolytic solution that contains glycolic acid, lactic acid, urea, and salicylic acid
Patients and relatives may also be advised to learn about the recession and patterns of recessive x-related ichthyosis. However, research into whether people can also be treated using gene transfer is currently ongoing.
Consult your physician about the most effective treatment choices for dominant X-linked ichthyosis.